/Investor DB

Amino Collective — Full Portfolio

64 tracked investments · listed companies and verified rows first

Animaanimahealth.comin𝕏Seed · Oct 2023

Anima is a healthcare platform that combines online consultation with productivity tools, featuring EHR integration, advanced analytics, and AI-powered document processing to streamline primary care workflows and improve patient outcomes.

AI & Machine LearningDigital HealthHealthtechSaaSLondon, GB

Shun Pang(Founder)inRachel Mumford(Founder)inInga Deakin(Director)Shun Pang Rachel Mumford(Founder)Jayanth Kottapalli(Engineering)inRuoni Wang(Engineering)in

Co-investorsHetz VenturesHummingbird VenturesMizMaa VenturesMolten VenturesY CombinatorHarvard Management Company+1 more

Animaanima.supply𝕏Mar 2024 · $12M

Anima is a gaming and interactive technology company that uses artificial intelligence to create virtual characters and worlds.

AI & Machine LearningConsumerGaming

Co-investorsCoinbase VenturesLD CapitalNarcissus VenturesYBB FoundationHummingbird VenturesMolten Ventures+1 more

Biomiabiomia.comin

Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics.

BiotechHealthtech

Co-investorsBlueYard CapitalNucleus Capital

Calibregetcalibre.comPre-Seed · Apr 2026 · $3M

Calibre is a UK membership-based preventative health service that pairs members with a dedicated doctor and AI to combine lab diagnostics, wearable data, and medical records into a personalised health assessment and ongoing care plan.

AI & Machine LearningDigital HealthHealthtechLondon, GB

Dr Reinhold Innerhofer(Chief Medical Officer)Dr Samantha Field(First Clinician)Dr Priyesh Parekh(Clinician)

CoSyne Therapeuticscosyne.comin𝕏

Cosyne operates a platform that combines biology, computation, and finance, using a hub-and-spoke model to spin out assets into subsidiaries as a distributed portfolio approach.

AI & Machine LearningBiotechDeep TechHealthtechLondon, GB

Michael Johnson(CMO & Co-Founder)

Co-investorsBackedBY Venture PartnersCrane Venture PartnersLocalGlobeStart CodonARC VENTURES

Cradlecradle.bioin

Cradle uses AI to help scientists design and engineer proteins, decoding and rewriting biology to develop new food sources, materials, and therapeutics.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareAmsterdam, NL

Stef van Grieken(Founder)inEli Bixby(Founder)inJelle Prins(Founder)inElise de Reus(Founder)in

BoardClaus Fuglsang Crone(Chief Scientific Officer, Novonesis)

Co-investorsIndex VenturesIVP (Institutional Venture Partners)Kindred Capital

Enveda Biosciencesenveda.comin𝕏

Enveda operates a drug-discovery platform that analyzes natural samples—primarily plant-derived molecules—using mass spectrometry, AI foundation models, and automated high-throughput labs to identify their chemical structures and therapeutic properties.

AI & Machine LearningBiotechDeep TechBoulder, US

Viswa Colluru(Founder)inDaniel Wee(Executive Officer)Pieter Dorrestein(Founder)Viswa Colluru Pieter Dorrestein(Founder)

BoardRohit Sharma(Director)Zavain Dar(Director)in

Co-investorsBoulder VenturesCatalio Capital Management, LPCox EnterprisesFPVGaingelsHummingbird Ventures+21 more

ExpressionEditsexpressionedits.comMay 2024 · $13M

ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.

AI & Machine LearningBiotechDeep Tech

Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)

Co-investorsBlueYard CapitalHAWKTAILMK Venture CapitalOctopus VenturesAcequia Capital (AceCap)redalpine+1 more

Frontier Computingfrontier.siteSeed

Frontier Computing grows lab-cultured biological neural networks at large scale to serve as a training substrate for machine learning, colocating memory and compute to support training of large-parameter models.

Advanced ManufacturingAI & Machine LearningHardwareLondon, GB

Michael Domarkas(CEO)in

Co-investorsKAYALocalGlobePhoenix CourtPioneerSpot VCWSS+20 more

Fundrbirdfundrbird.com

Fundrbird provides software solutions for GP (general partner) firms to build and scale their fund management operations.

Enterprise SoftwareFintechSaaS

Bram van Esch(Founder)in

Co-investorsCuriosity VCEndeit CapitalHealthy.CapitalHolland CapitalMundi VenturesPride Capital Partners+5 more

Hederahederadx.comin𝕏

Hedera Dx develops in-house, NGS-based liquid biopsy tests and clinicogenomic data solutions for decentralized oncology care, partnering with laboratories and clinicians to support cancer diagnosis and personalized therapy selection.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Tommi Lehtonen(CEO, Co-founder)inDamien Lapray(CCO, Co-founder, PhD)inChristian Meisel(CMO, Co-founder, MD PhD)inFrances Rhodius(CFO)

Co-investorsBootstrap EuropeHelsana HealthInvest AGInventureInventureTesi (Finnish Industry Investment Ltd)Vsquared Ventures

Huminlyhuminly.comin𝕏

Huminly uses engineered enzymes to separate mixed poly-cotton textile waste into pure polyester monomer and pure cotton, enabling textile-to-textile recycling.

Circular EconomyCleantechNew Materials

Nikita Khlystov(Founder and CEO)inSean Hunt(Co-founder and CTO)

Co-investorsFifty Years

Inductive Bioinductive.bioin𝕏Mar 2025

Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.

AI & Machine LearningBiotechDeep TechBrooklyn, US

Josh Haimson(Executive Officer, Director)inBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)in

BoardRohan Ganesh(Director)in

Co-investorsAlleyCorpAndreessen HorowitzCoalition OperatorsEnsemble LabsLux CapitalObvious Ventures+6 more

Junctionjunction.comin𝕏Seed · Mar 2025

Junction provides a unified API platform that connects healthcare providers, wellness companies, and EHR systems to a nationwide network of labs and 300+ medical devices.

Data & InfrastructureHealthtechSaaSWellness & FitnessLondon, GB

Maitham Dib(Founder)inFemi AwomosuNaomi Yudanin(Head of Data \u0026 AI)Rui Peres(Head of Engineering)Simba Deu(Chief of Staff)Beth Toms(Head of Talent)

Co-investors20VCAdventure FundAlliance DAO (ex DeFi Alliance)Canyon Creek CapitalGaingelsInvestindustrial+7 more

Junction AIjunction.aiMar 2025 · $18M

Junction AI is a Managed Intelligence Partner that builds, deploys, and manages production AI systems micro-tuned on a company's proprietary data, with built-in compliance rules, audit trails, and human-in-the-loop review.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsBlue StartupsHawke VenturesCreandumInflect HealthOmnivorePoint Nine+1 more

Kano Therapeuticskanotherapeutics.comin𝕏May 2024

Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a genetic payload for gene-editing and other DNA-based therapies, offering an alternative to viral vectors and double-stranded DNA.

BiotechDeep TechCambridge, US

Floris Engelhardt(Executive Officer, Director)John Vroom(Director)

BoardAnn DeWitt(Director)in

Co-investorsFifty YearsLaunchpad Venture GroupMetaplanetThe Engine VenturesVsquared VenturesZAKA VC

Kernal Biologicskernalbio.comin𝕏Series A · Jul 2022 · $25M

Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)Burak YILMAZ(Founder)in

Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesGaingelsHOF CapitalHummingbird Ventures+14 more

Lindus Healthlindushealth.comin𝕏

Lindus advances pharmaceutical asset portfolios through an integrated clinical trial platform, partnering with biotech and pharma companies to accelerate drug development.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Meri Beckwith(Founder)Michael Young(Founder)inNik Haldimann(Founder)

Co-investorsBalderton CapitalCalm/Storm VCfirstminute capitalLoop VCSalica InvestmentsVisionaries Club+2 more

Lirlirtx.comin

Lir develops AI-driven viral vector engineering for gene therapy, using machine learning to optimize AAV (adeno-associated virus) vectors for improved dose efficiency, tissue targeting, and immune evasion.

AI & Machine LearningBiotechDeep Tech

Killian Hanlon(Co-founder)inHugh O'Brien(Co-founder)in

Co-investorsFly Ventures

Modern Relaymodernrelay.comin

Modern Relay builds infrastructure for companies running many background AI agents, centered on Omnigraph, a shared graph that connects data, workflows, decision history, and agent skills so multiple agents can coordinate over a common world model.

AI & Machine LearningData & InfrastructureEnterprise Software

Ragnor Comerford(Founder)in

Co-investorsMasiaCommon MagicPoint Nine

Molecule AImolecule.xyz𝕏

Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs.

AI & Machine LearningBiotechCrypto & Web3

Paul Kohlhaas(Founder)inNeeta Singal(Founder)Saurabh Singal(Founder)Saurabh Singal Neeta Singal(Founder)Tyler Golato(Founder)Vincent Weisser(Founder)in

Co-investors1k(x)1kxAtria VenturesBackedBoxGroupCompound+19 more

Nostosnostos-genomics.comin𝕏Pre-Seed · Feb 2022

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases.

AI & Machine LearningBiotechDigital HealthHealthtechBerlin, DE

David Gorgan(Co-founder)inRocio Acuna Hidalgo(Co-founder)in

Co-investors42CAPAcequia Capital (AceCap)Entrepreneur FirstFaberFrontline VenturesMK Venture Capital

Portal Biotechportalbiotech.comin

Portal Biotech develops bench-top instruments that use nanopore biosensors coupled with machine learning to detect, sequence, and characterise single protein and metabolite molecules, revealing modifications, mutations, and isoforms.

AI & Machine LearningBiotechDeep Tech

Co-investorsPillar VCEarlybird Venture Capital

Rematiqrematiq.comin

Rematiq builds an AI-driven platform for product and regulatory compliance in life sciences, connecting requirements, regulations, evidence and submissions in one system and automating traceability, compliance checks and document generation.

AI & Machine LearningHealthtechSaaS

David Boutellier-Saxer(Founder)in

Co-investorsProject A Ventures

Riviarivia.com

Rivia builds an AI-powered platform for clinical trials that integrates and harmonizes fragmented trial data from multiple vendors into standardized models, then applies AI agents for data quality checks, monitoring, and analysis.

AI & Machine LearningBiotechDigital Health

Co-investorsEarlybird Venture Capital

Sameric Biosameric.bio

Sameric Bio in-licenses multifunctional protein-based biologics (bispecifics, engagers, degraders, enzyme-linked proteins) from academic researchers and develops them from in-vivo/ex-vivo proof of concept to clinical proof of concept.

AI & Machine LearningBiotechDeep Tech

Alexander Belcredi(Co-Founder & CEO)Lorenzo Corsini(Co-Founder & CEO)Adriana Badarau(Co-Founder & CSO)Albina Poljak(Co-Founder & CPO)

Scale AIscale.comin𝕏Aug 2019

Scale provides a data-centric infrastructure platform that uses reinforcement learning with human feedback (RLHF) to help organizations build and develop AI models.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

Alexandr Wang(CEO)inLucy Guo(Founder)inFrancis deSouza(CEO)inTim Dingman(Strategic Product Manager)inCharles Lambert(Web Developer)Jesse Tinsley

Co-investors1435 CapitalAccelAdit Ventures Management, LlcAIspace VenturesAlpana VenturesAlpha Square Group+107 more

Scale Medicinescalemedicine.comDec 2023

Scale Medicine is an AI-native pharmaceutical company that applies artificial intelligence to improve the success rates of its clinical trials.

AI & Machine LearningBiotechDigital HealthNew York, US

Michael Retchin(Executive Officer, Director)

Sensible Biotechnologiessensible.bioin𝕏Seed

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in

BoardVishal Gulati(Director)Joel Schoppig(Director)

Co-investorsCivilization Ventures Management, LlcIn-Q-TelKAYARecode VenturesTech HorizonsTraun Ventures+13 more

Seqeraseqera.ioin𝕏

Seqera is a bioinformatics platform that centralizes scientific data, orchestrates pipelines, and provides governance, auditability, and reproducibility across on-premises and cloud environments (AWS, GCP, Azure).

AI & Machine LearningBiotechData & Infrastructure

Evan Floden(Founder)inPaolo Di Tommaso(Founder)

Co-investorsSpeedinvestAdditionbacktrace capitalBoxOne VenturesTalis Capital

Serna Bioserna.bioin𝕏Seed

Serna builds a platform to unlock the transcriptome as a drug target for drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechOntario, US

Rabia Khan(Founder)inAaron Lazarus(Chief of Staff)inPaul Bradley-Law(Head of People Ops)

Co-investorsBackedHummingbird VenturesLifeforce CapitalY CombinatorAME Cloud VenturesAxial VC+3 more

Tandem Healthtandemhealth.aiinJun 2025

Tandem Health builds regulated clinical AI for clinicians and health systems, including an AI scribe that generates clinical documents and diagnosis/procedure codes (ICD-10, SNOMED), a coding assistant, and clinical decision support certified as EU MDR Class IIa medical devices.

AI & Machine LearningDigital HealthHealthtech

Lukas Saari(Founder)inOliver Astrand(Founder)Oscar Boldt-Christmas(Founder)

Co-investorsGROOVE CAPITALIdeashipInception FundKinnevikNorthzoneEQT+1 more

THEOREMAtheorema.ai

Hynek Walner(Founder)

Co-investorsi&i Biotech FundTilia Impact PartnersTilia Impact Ventures

Validvalidtx.com

VALID builds human iPSC-derived co-culture disease models and pairs them with automated high-throughput perturbation screening and multimodal measurement (imaging, RNA-seq, proteomics) to generate AI-ready biological data for drug discovery.

AI & Machine LearningBiotechDeep Tech

Tim Ahfeldt(Co-Founder & CEO)Josh Lamstein(Co-Founder & CFO/COO)Ole Wiskow(Head of Platform)Rob Moccia(Head of AI and Data)Tony Asher(Chief Information Security Officer)

Vira Healthvira.healthin

Vira Health provides digital clinical care and support services for women's and men's health across all life stages, partnering with healthcare systems and employers.

Digital HealthFemTechHealthtechHR TechWellness & Fitness

Andrea Berchowitz(Founder)inHolly Scheirin

Co-investorsLocalGlobeMMC VenturesNina CapitalNovaCapitalOctopus VenturesOptum Ventures+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AI-Native Drug Discovery CROAllcyteCancer Drug Discovery PlatformClinical Trial AI PlatformClinical Trials PlatformClinician CopilotDrug Discovery Prediction PlatformEnterprise AI Context GraphExscientiaGene Therapy PlatformGenomic Data PlatformHealth Data Integration PlatformLindusLiquid Biopsy PlatformMedicinal Plant Drug DiscoverymRNA Cancer TreatmentNanopore Proteomics PlatformPrecision Fermentation Drug DiscoveryProtein Design PlatformRNA Therapeutics ManufacturingScience IP-NFT MarketplaceScientific R&D AutomationSubstrate BioSynthetic DNA Gene ExpressionTelemedicine PlatformTextile Waste RecyclingTranscriptome Discovery PlatformVirtual Patient ModelingWomen's Health Digital Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.